GCKR and metabolic dysfunction-associated steatohepatitis: When compared to matched healthy controls, GCKR gene variants were not associated with NASH or severe liver disease (hepatic decompensation or HCC) after adjusting for factors including age, gender, body mass index (BMI), and the risk ratio for T2D using Cox regression.